Follicular helper T-cell lymphoma, follicular-type

Clinical trials for Follicular helper T-cell lymphoma, follicular-type explained in plain language.

Never miss a new study

Get alerted when new Follicular helper T-cell lymphoma, follicular-type trials appear

Sign up with your email to follow new studies for Follicular helper T-cell lymphoma, follicular-type, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Experimental combo targets rare lymphoma in early trial

Disease control Recruiting now

This phase 1 trial is testing whether adding the drug ruxolitinib to standard CHOP chemotherapy is safe and effective for people with untreated nodal T-follicular helper (TFH) cell lymphoma, a rare type of non-Hodgkin lymphoma. About 20 adults will receive the combination to find…

Matched conditions: FOLLICULAR HELPER T-CELL LYMPHOMA, FOLLICULAR-TYPE

Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control

Last updated Jun 27, 2026 13:03 UTC

Follicular helper T-cell lymphoma, follicular-type

Get alerted when new Follicular helper T-cell lymphoma, follicular-type trials appear

Experimental combo targets rare lymphoma in early trial